About this trial
Clinical Study Overview Feasibility Study Plan (Study 1: Healthy Participants) Study 1- Confirming Flower capsule performance characteristics in detection of retained gastric contents greater than 1.5mL/kg in Healthy volunteers
1\. Study Purpose
a. A controlled, prospective, between-participants study design to assess Flower in detecting the presence or absence of retained gastric contents (RGC), using sedated esophagogastroduodenoscopy (EGD) as the ground truth for an empty stomach and known ingested volume as the ground truth for a fed participant.
2\. Study Endpoints
a. Primary i. Visualization of Retained Gastric Contents b. Secondary i. Gastric mucosal visualization of the seven anatomical landmarks of the stomach (fundus, cardia, lesser gastric curvature, greater gastric curvature, angulus, antrum, and pylorus) ii. Gastric Cleanliness iii. Adverse events defined as capsule retention, capsule aspiration, perforation, nausea, and pain iv. Maximum, tolerated water consumed v. Patient tolerance vi. Exploratory attempts for successful swallowing vii. Exploratory minimum and maximum water volume for optimal Flower performance viii. Time required for gastric examination completion by Flower
Eligibility criteria
Qualifiers
Age > 18 years and < 65 years (male or female)
Willing and able to sign an IEC-approved informed consent form
Willing and able to comply with all study requirements
Disqualifiers
History of gastrointestinal disorders
History of gastroparesis
History of prior gastric surgery
Swallowing disorders
Trial design
Treatments tested in this trial
- Flower
Treatment groups
Sponsors and collaborators
Asian Institute of Gastroenterology, India
Lead sponsor
Endiatx
Collaborator